Skip to main content
Translational Oncology logoLink to Translational Oncology
. 2025 Mar 16;55:102354. doi: 10.1016/j.tranon.2025.102354

Corrigendum to “Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients” [Translational Oncology, volume 49 (2024), 102106]

Ka-Liong Tan a,e,, Syed Haider b,c,f, Christos E Zois b, Jianting Hu a, Helen Turley b, Russell Leek b, Francesca Buffa c, Oreste Acuto d, Adrian L Harris b, Francesco Pezzella a,
PMCID: PMC12242585  PMID: 40221214

The authors regret the omission of funding support in the original manuscript. This work was supported by Cancer Research UK via the Centre Support Programme (H3R00390). The authors would also like to acknowledge this funding in the manuscript's Acknowledgements section.

The authors apologise for any inconvenience caused.

Contributor Information

Ka-Liong Tan, Email: tankaliong8@gmail.com, kaliong_tan@usim.edu.my.

Francesco Pezzella, Email: francesco.pezzella@ndcls.ox.ac.uk.


Articles from Translational Oncology are provided here courtesy of Neoplasia Press

RESOURCES